Messaggi
4Today I was able to open my first position $IPS (+1,65%) . Unfortunately, I didn’t quite catch the dip—I didn’t have any cash on hand at that moment. Still, I’m happy with the entry. Good dividend yield and growth. Once again, thanks for the tip to my dear @investron . I hope we’ll see a similar trend here as with $EDEN (+2%) .
If the price pulls back a bit more, I’d be happy to add to my position. Price alert is set.
I don't have it in my portfolio yet, but as has become tradition, I buy any stock that my algorithm ranks at the very top, after a human review. Here are its numbers:
$IPS (+1,65%) 🟢 OPTIMAL | Quality 80, Opportunity 92
Yield 5.17% | P/E 9.68x | Debt/EBITDA 0.87x
The dividend consumes only 26.6% of cash flow
Ipsos is the world’s third-largest market research group. Surveys, consumer panels, data for businesses and governments. It’s not a very exciting business, but it has an interesting advantage: every time privacy laws get stricter, its proprietary consumer panels become more valuable.
The reason for the sell-off: The CEO suddenly resigned a few weeks ago, after just one year in the role. In the three companies I’ve worked for throughout my career, whenever a CEO “resigned,” there were other reasons behind it. So we need to approach this stock with caution.
The stock dropped 9% and has remained there. Revenue continues to grow, the balance sheet is clean, and the company has just approved a €300M buyback.
The risks? Generative AI could eat into the market share of traditional surveys. This is no minor risk. But it’s not exactly Blockbuster vs. Netflix either: Ipsos has been investing in its own technology for years.
At 9.7x P/E with a well-covered 5.2% yield, I believe the market is pricing in a decline that hasn’t happened yet.
Update on $IPS (+1,65%) — H1 2026 results
Following up on my Ipsos position — half-year numbers out
Q2 revenue: €615.2m, +4.9% (organic +3.0%) — rebound after Q1's -1.4%
H1 revenue: €1,170.1m, +1.3% (organic +0.8%, back to positive)
H1 net profit: €40.9m
Order book: organic +1.6% (end Q2) vs +1.0% (end Q1) — supports H2
Drivers: Public Affairs, Consumer Goods, China; pharma + UK improving
EMEA (largest region): +5.6% H1
Guidance: FY organic ~2%, margin in line with 2025 — maintained
Strategy: Horizons plan (AI + "Speed" fast-turnaround)
Take: not a blockbuster, but solid sequential improvement — Q2 organic +3%, order book building, guidance intact.
Low double-digit P/E + ~5% yield. Comfortable holding.
Anyone else digging through European mid-cap earnings this season? I mean outside Germany?
As part of my portfolio rebalancing, I've been looking for undervalued European stocks to reduce my exposure to the volatility and concentration risk of US tech, the Thumps USA and USD. After some research, I decided to open a position in French market research leader Ipsos. $IPS (+1,65%)
Why Ipsos?
The company is one of the world's top three market research firms, operating in 90+ markets with a diversified client base across industries. What caught my attention:
The market research industry is relatively resilient even during economic downturns, as companies still need consumer insights to make informed decisions. Ipsos has also been investing in digital capabilities and data analytics, positioning itself well for the future.
The European angle: While everyone's piling into highly volatile AI-related tech stocks, I'm finding better risk/reward in overlooked European quality stocks trading at reasonable multiples. At €34, Ipsos looks particularly compelling.
What do you think? Anyone else holdin $IPS (+1,65%) or considering European value plays right now?
Does anyone agree with this choice?
